13349-91-2

Basic information

• Product Name: 1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride
• Synonyms: 1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride;Piperazine,1-(2,2,2-trifluoroethyl)-, dihydrochloride;1-(2,2,2-TRIFLUOROETHYL)PIPERAZINE 2HCL
• CAS NO: 13349-91-2
• Molecular Formula: C6H13F3N2Cl2
• Molecular Weight: 241.08
• Mol File: 13349-91-2.mol
• Article Data: 4

Chemical Properties

• Melting Point: 198-205 °C
• Boiling Point: 233.7 °C at 760 mmHg
• Flash Point: 95.2 °C
• Appearance: /
• Vapor Pressure: 0.0445mmHg at 25°C
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride(13349-91-2)
• EPA Substance Registry System: 1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride(13349-91-2)

Safety Data

• Hazardous Substances Data: 13349-91-2(Hazardous Substances Data)

Usage

General Description

1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride is a chemical compound that consists of a piperazine ring with a trifluoroethyl group attached to it. It is commonly used as a building block for the synthesis of various pharmaceutical compounds, including potential drug candidates for the treatment of central nervous system disorders and other medical conditions. As a dihydrochloride salt, it is highly soluble in water and is often used in aqueous solutions for research and development purposes. 1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride is known for its potential pharmacological properties and has been studied for its effects on the central nervous system, with potential applications in the field of neurology and psychiatry.

InChI:InChI=1/C6H11F3N2.2ClH/c7-6(8,9)5-11-3-1-10-2-4-11;;/h10H,1-5H2;2*1H

Upstream product

• 692058-21-2 4-(2,2,2-trifluoroethyl)piperazin-1-carboxylic acid tert-butyl ester 

Downstream Products

• 13349-90-1 1-(2,2,2-trifluoroethyl)piperazine 

Relevant articles and documents

SUBSTITUTED PYRAZOLE COMPOUNDS AND METHODS OF USING THEM FOR TREATMENT OF HYPERPROLIFERATIVE DISEASES

Disclosed are compounds useful, for example, in methods of treating hyperproliferative disorders such as cancer, methods of arresting the cell cycle in cancer cells, methods of inhibiting glutathione synthesis in cancer cells, and associated compounds for

QUINAZOLINE DERIVATIVES AS SRC TYROSINE KINASE INHIBITORS

The invention concerns quinazoline derivatives of Formula (I): (A chemical formula should be inserted here - please see paper copy enclosed herewith) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)2 group wherein each R2 group is hydrogen or (1-8C) alkyl, m is 0, 1, 2 or 3, each R1 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, n is 0, 1, 2 or 3, and each R3 group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, or pharmaceutically-acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.